Atlas Trials

Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors

Clinical trial NCT01225172 · TERMINATED

Trial details

NCT number
NCT01225172
Sponsor
Bristol-Myers Squibb
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2010-12-31
Primary completion
2014-11-30
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.